Leaflet:information for the patient
BisoprololCombix5 mg film-coated tablets EFG
bisoprolol fumarate
Read the entire leaflet carefullybefore starting to take thismedication,as it contains important informationfor you.
Contents of the leaflet
5 Conservation of Bisoprolol Combix
The active ingredient of this medication is bisoprolol. Bisoprolol belongs to a group of medications called beta-blockers. These medications work by affecting the body's response to certain nerve impulses, especially in the heart. As a result, bisoprolol slows down the heartbeat and makes the heart more efficient, pumping blood throughout the body.
Heart failure occurs when the heart muscle is weak and unable to pump enough blood to meet the body's needs. Bisoprolol is used to treat chronic stable heart failure.
Bisoprolol is used in combination with other medications suitable for this condition (such as ACE inhibitors, diuretics, and cardiac glycosides).
Do not takeBisoprolol Combix
Do not take bisoprolol if you have any of the following conditions:
Do not take bisoprolol if you have any of the following heart problems:
Warnings and precautions
Consult your doctor or pharmacist before starting to take bisoprolol.
If you have any of the following problems, consult your doctor before starting to take bisoprolol; your doctor may want to take special precautions (such as providing additional treatment or performing more frequent tests):
In addition, inform your doctor if you are going to undergo:
If you have chronic lung disease or less severe asthma, inform your doctor immediately if you start to notice breathing difficulties, coughing, wheezing after exercise, etc. while using bisoprolol.
Children and adolescents
The use of bisoprolol is not recommended in children or adolescents.
Other medications and Bisoprolol Combix
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
Do not take the following medications with bisoprolol without special advice from your doctor:
Consult your doctor before taking the following medications with bisoprolol; your doctor may need to monitor your condition more frequently:
Pregnancy andbreastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
There is a risk that using bisoprolol during pregnancy may harm the baby. If you are pregnant or plan to become pregnant, inform your doctor. Your doctor will decide if you can take this medication during pregnancy.
Breastfeeding
It is unknown whether bisoprolol passes into human breast milk. Therefore, breastfeeding is not recommended during treatment with bisoprolol.
Driving and using machines
Your ability to drive or use machinery may be affected depending on how you tolerate the medication. Be especially careful when starting treatment, when the dose is increased, or the medication is changed, and also in combination with alcohol.
BisoprololCombixcontains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially "sodium-free".
Follow the administration instructions for this medication indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Treatment with bisoprolol requires regular monitoring by your doctor. This is particularly necessary at the start of treatment, during dose increase, and when stopping treatment.
Take the tablet with a little water in the morning, with or without food. Do not crush or chew the tablet. The tablet can be divided into equal doses.
Treatment with this medication is usually long-term.
Adults, including elderly patients
Treatment with bisoprolol should be started at a low dose and gradually increased.
Your doctor will decide how to increase the dose, and this will normally be done as follows:
The maximum recommended daily dose is 10 mg of bisoprolol.
Depending on how well you tolerate the medication, your doctor may also decide to prolong the time between dose increases. If your condition worsens or you no longer tolerate the medication, it may be necessary to reduce the dose again or interrupt treatment. In some patients, a maintenance dose lower than 10 mg of bisoprolol may be sufficient. Your doctor will tell you what to do.
Normally, if you need to stop treatment completely, your doctor will advise you to gradually reduce the dose, as otherwise, your condition may worsen.
If you take more Bisoprolol Combix than you should
If you have taken more bisoprolol tablets than you should, inform your doctor immediately. Your doctor will decide what actions are necessary.
The symptoms of an overdose may include a reduction in heart rate, severe breathing difficulties, dizziness, or tremors (due to low blood sugar). In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Bisoprolol Combix
Do not take a double dose to make up for forgotten doses. Take the usual dose the next morning.
If you stop taking Bisoprolol Combix
Never stop taking bisoprolol unless your doctor tells you to. Otherwise, your condition could worsen significantly.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
To prevent serious adverse reactions, talk to a doctor immediately if a side effect is severe, occurs suddenly, or worsens rapidly.
The most serious side effects are related to heart function:
If you feel dizzy or weak, or have breathing difficulties, contact your doctor as soon as possible.
Other side effects are mentioned below according to their possible frequency of occurrence:
Frequent(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very rare(may affect up to 1 in 10,000 people):
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store above 30 ºC.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and unused medications at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Bisoprolol Combix 5 mg film-coated tablets EFG
Tablet core: silicified microcrystalline cellulose, sodium croscarmellose, type A potato carboxymethyl starch, and magnesium stearate.
Tablet coating: coating agent (composed of hypromellose, macrogol, and titanium dioxide (E171)).
Appearance of the product and package contents
The film-coated tablets are white or almost white, round, biconvex, with a diameter of approximately 8.50 mm, marked with the inscription "5" on one face and scored on the other.
They are presented in blister packs in containers containing 28, 30, or 60 film-coated tablets.
Marketing authorization holder and manufacturer
Marketing authorization holder
Laboratorios Combix, S.L.U.
C/ Badajoz 2, Edificio 2
28223 Pozuelo de Alarcón (Madrid)
Spain
Manufacturer
Zydus FranceZAC Les Hautes PaturesParc d'activités des Peupliers25 Rue des Peupliers92000 NanterreFrance
or
Centre Specialites Pharmaceutiques
Z.A.C. du Suzot
35 Rue de la Chapelle
63450 Saint Amant Tallende
France
or
Netpharmalab Consulting Services
Carretera de Fuencarral 22,
Alcobendas,
28108 Madrid
Spain
Date of the last revision of this leaflet: April 2025
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)